🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Proteome-wide analysis identifies plasma immune regulators of amyloid-beta progression

Brain Behavior and Immunity(2024)10.1016/j.bbi.2024.07.002Source: DataRank Database

Proteome-wide analysis identifies plasma immune regulators of amyloid-beta progression is a research paper published in Brain Behavior and Immunity (2024). On theSindex it has a DataRank of 0.425. It has been cited 16 times.

N/A

0.425DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Cite:

Linked data & code

hPSCreg refsnp doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (102 grants)Impact (FWCI 3.98)OA: hybridTopics (72)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.425

From this paper's citation signal

Citation Network Contribution

0

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (27)

Gabriela Gómez ORCID,Cassandra M Joynes,Murat Bilgel ORCID,Jingsha Chen,Nicola Fattorelli ORCID

Live enrichment

PubMed:38977137 PMC:PMC11682725 OpenAlex:https://openalex.org/W4400381161

Stiftelsen för Gamla Tjänarinnor

Grant: FO2022-0270

H2020 Marie Skłodowska-Curie Actions

Grant: 860197

Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis

UK Dementia Research Institute

Grant: R01 AG075336-01

UK Dementia Research Institute

Grant: 2021-03244

UK Dementia Research Institute

Grant: U24 AG082930-01

UK Dementia Research Institute

Grant: R01 AG072641-02

UK Dementia Research Institute

Grant: R01 AG073267-02

UK Dementia Research Institute

Grant: R01 AG083874-01

UK Dementia Research Institute

Grant: R37 AG023651-17

UK Dementia Research Institute

Grant: P01 AG025204-16

UK Dementia Research Institute

Grant: RF1 AG025516-12A1

UK Dementia Research Institute

Grant: R01 AG053952-05

UK Dementia Research Institute

Grant: P30 AG066468

UK Dementia Research Institute

Grant: UKDRI-1003

UK Dementia Research Institute

Grant: RF1 AG052525-01A1

Emil och Wera Cornells Stiftelse

Grant: AF-939721

Emil och Wera Cornells Stiftelse

Grant: 2022-00732

Emil och Wera Cornells Stiftelse

Grant: AF-930351

Emil och Wera Cornells Stiftelse

Grant: AF-968270

Emil och Wera Cornells Stiftelse

Grant: 2017-00915

NIA

Grant: 75N95D19P0017

NIA

Grant: P30 AG066507

NIA

Grant: R01AG040282

NIA

Grant: U19AG033655

Alzheimer's Drug Discovery Foundation

Grant: 201809-2016862

Vetenskapsrådet

Grant: 2022-01018

Vetenskapsrådet

Grant: 2019-02397

Alzheimer's Association

Grant: AARF-21-850325

Alzheimer's Association

Grant: ADSF-21-831381-C

Alzheimer's Association

Grant: ADSF-21-831376-C

Alzheimer's Association

Grant: ADSF-21-831377-C

Hjärnfonden

Grant: ALZ2022-0006

Hjärnfonden

Grant: FO2017-0243

BrightFocus Foundation

Grant: A2021034S

Universiteit Antwerpen

Grant: BOF-TOP 2022-2025

Universiteit Antwerpen

Grant: 2018-AARF-591110-RAPID

Universiteit Antwerpen

Grant: ERC-834682-358

Universiteit Antwerpen

Grant: 2018-AARF-591110

Fonds Wetenschappelijk Onderzoek

Grant: 1139520N

Fonds Wetenschappelijk Onderzoek

Grant: AARF-20-684397

NHLBI

Grant: 75N92022D00001

NHLBI

Grant: 75N92022D00004

NHLBI

Grant: 75N92022D00003

NHLBI

Grant: 75N92022D00002

NHLBI

Grant: 75N92022D00005

NHLBI

Grant: U01HL096812

NHLBI

Grant: U01HL096899

NHLBI

Grant: U01HL096814

NHLBI

Grant: U01HL096917

NHLBI

Grant: U01HL096902

NIA NIH HHS

Grant: R01 AG083874

Intramural NIH HHS

Grant: Z99 AG999999

European Research Council

Grant: 834682

NIA NIH HHS

Grant: R01 AG072641

NIA NIH HHS

Grant: U01 AG033655

NIA NIH HHS

Grant: R01 AG073267

NIA NIH HHS

Grant: RF1 AG025516

Intramural NIH HHS

Grant: ZIA AG000348

NIA NIH HHS

Grant: R01 AG053952

NIA NIH HHS

Grant: R01 AG075336

NIA NIH HHS

Grant: R37 AG023651

NIA NIH HHS

Grant: U24 AG082930

NIA NIH HHS

Grant: P01 AG025204

NIA NIH HHS

Grant: RF1 AG052525

NIA NIH HHS

Grant: U24 AG074855

Intramural NIH HHS

Grant: ZIA AG000349

Swedish Research Council

Grant: unidentified

unidentified

National Institutes of Health

Grant: 2RF1AG025516-12A1

Roles of Gray Matter Brain Aging and Small Vessel Disease in AD Pathophysiology

National Institutes of Health

Grant: 5R37AG023651-17

Mild Cognitive Impairment: A Prospective Community Study

National Institutes of Health

Grant: 5U19AG033655-12

Biomarkers of Cognitive Decline Among Normal Individuals: The Biocard Cohort

National Institutes of Health

Grant: 5R01AG073267-03

Longitudinal multicenter head-to-head harmonization of tau PET tracers

National Institutes of Health

Grant: 5R01AG075336-04

Head-to-head comparisons of high-performance plasma phospho-tau epitopes for the detection of Alzheimer's disease

National Institutes of Health

Grant: 1R01AG072641-01A1

Predictors of Altered CNS Structure, Function, and Connectomics in the Elderly using a Health Disparities Framework

National Institutes of Health

Grant: 1RF1AG052525-01A1

Subclinical vascular disease and AD pathology in the transition from midlife to old age

National Institutes of Health

Grant: 5U01HL096902-06

ARIC Neurocognitive Study (ARIC-NCS)

National Institutes of Health

Grant: 1U24AG082930-01

Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network

National Institutes of Health

Grant: 2U01HL096917-05

ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5

National Institutes of Health

Grant: 5U01HL096814-02

ARIC Neurocognitive Study (ARIC-NCS)

National Institutes of Health

Grant: 3P30AG066468-01S1

Comparison of tau-PET tracers: Progress towards a universal measure

National Institutes of Health

Grant: 5U01HL096812-08

ARIC Neurocognitive Study (ARIC-NCS) 1 of 5

European Commission

Grant: 101053962

Fluid Biomarkers for Neurodegenerative Dementias

National Institutes of Health

Grant: 5R01AG040282-03

The ARIC-PET Amyloid Imaging Study

National Institutes of Health

Grant: 5R01AG083874-02

Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood

National Institutes of Health

Grant: 2P01AG025204-06

Imaging, Methodology and Statistics Core

European Commission

Grant: 101041867

Deciphering the microglia-neuron interactions in human Alzheimer's disease

National Institutes of Health

Grant: 5P30AG066507-03

Johns Hopkins Alzheimer's Disease Research Center

University College London Hospitals Biomedical Research Centre

Vlaams Instituut voor Biotechnologie

Erling-Perssons Stiftelse

National Institute of Neurological Disorders and Stroke

Olav Thon Stiftelsen

Alzheimerfonden

Alzheimer’s Research UK

Horizon 2020 Framework Programme

National Institutes of Health

Horizon 2020

Intramural Research Program

KU Leuven

Medical Research Council

Vlaamse regering

Alzheimer's Society

National Institute on Deafness and Other Communication Disorders

FWCI

3.98

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.bbi.2024.07.002

publisherhttps://doi.org/10.1016/j.bbi.2024.07.002

publisherhttps://api.elsevier.com/content/article/PII:S0889159124004719?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0889159124004719?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38977137

Fields of Study

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsTryptophan and brain disorders

MeSH Terms

AgedAged, 80 and overAgingAlzheimer DiseaseBrainFemaleHumansLongitudinal StudiesMaleMiddle AgedBiomarkersAmyloid beta-PeptidesDisease ProgressionProteomePositron-Emission Tomography

Keywords

Immune systemAmyloid betaBiomarkerBiologyAmyloid (mycology)ImmunologyNeuroscienceDiseaseMedicineInternal medicinePathologyGeneticsProteomicsPositron emission tomographyAlzheimer’s diseaseAmyloid-betaMaleAgingProteomeASTROCYTOSISAGEAlzheimer DiseaseHumansAlzheimer 's diseaseLongitudinal StudiesBRAINDEPOSITIONLIFE-SPANACCUMULATIONAgedPsychiatryAged, 80 and overScience & TechnologyNeurology & NeurosurgeryAmyloid beta-PeptidesNeurosciencesMiddle AgedMICROGLIAL ACTIVATIONALZHEIMERS-DISEASE3204 ImmunologyPET1107 Immunology1701 Psychology5202 Biological psychologyPositron-Emission TomographyONSET3209 NeurosciencesDisease ProgressionFemaleHuman medicineNeurosciences & Neurology1109 NeurosciencesLife Sciences & BiomedicineBiomarkers

Sustainable Development Goals

SDG 0: Zero hunger

Related Papers (9)

Discovery of novel CSF biomarkers to predict progression in dementia using machine learning

Scientific Reports(2023)

co-cited

10.1038/s41598-023-33045-x

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

N/A

1.2DataRank · unranked

Alzheimer s & Dementia(2024)

co-cited

10.1002/alz.13859

Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease

N/A

0.843DataRank · unranked

Nature Reviews Neurology(2024)

co-cited

10.1038/s41582-024-00977-5

Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology

N/A

0.657DataRank · unranked

EBioMedicine(2024)

co-cited

10.1016/j.ebiom.2024.105046

Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p‐tau217 immunoassays

N/A

0.661DataRank · unranked

Alzheimer s & Dementia(2024)

co-cited

10.1002/alz.14140

Plasma p-tau217 in Alzheimer’s disease: Lumipulse and ALZpath SIMOA head-to-head comparison

N/A

0.606DataRank · unranked

Brain(2024)

co-cited

10.1093/brain/awae368

The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study

Top 18%

1.2DataRank

Alzheimer s & Dementia(2025)

co-cited

10.1002/alz.14508

Exploratory analysis of the proteomic profile in plasma in adults with Down syndrome in the context of Alzheimer's disease

Alzheimer s & Dementia(2025)

co-cited

10.1002/alz.70040

Clinical diagnosis of Alzheimer's disease

N/A

1.5DataRank · unranked

Neurology(1984)

co-cited

10.1212/wnl.34.7.939